1,8-Diazabicyclo(5.4.0)undec-7-ene → 2-(2-Methyl-imidazol-1-yl)-7-pyridin-2-yl-[1,2,4]triazolo[1,5-a]pyridin-5-ylamine
반응식
CS([C:4]1[N:19]=[C:7]2[CH:8]=[C:9]([C:13]3[CH:18]=[CH:17][CH:16]=[CH:15][N:14]=3)[CH:10]=[C:11]([NH2:12])[N:6]2[N:5]=1)=O.[N:20]12[CH2:30][CH2:29]C[N:27]=[C:26]1[CH2:25]CCCC2>CC1NC=CN=1>[CH3:25][C:26]1[N:20]([C:4]2[N:19]=[C:7]3[CH:8]=[C:9]([C:13]4[CH:18]=[CH:17][CH:16]=[CH:15][N:14]=4)[CH:10]=[C:11]([NH2:12])[N:6]3[N:5]=2)[CH:30]=[CH:29][N:27]=1참가 물질
4
실험 절차
The title compound, MS m/e (%):292 (M+H+,100), was prepared in accordance with the method of example 339b) from 2-methanesulfinyl-7-pyridin-2-yl-[1,2,4]triazolo[1,5-a]pyridin-5-ylamine and 1,8-diazabicyclo[5.4.0]undec-7-en in 2-methylimidazole at 170° C.
출처 및 근거
- ORD 기록
- ord-6bfe6746b57c4ed5bae45fa92cce01fc
- 출처 데이터셋
- uspto-grants-2002_03
- 특허 번호
- US06355653B1
반응 노트
불러오는 중…